Kuftive Syrup is a combination pharmaceutical formulation containing Phenylephrine (5mg/5ml), Chlorpheniramine Maleate (2mg/5ml), and Dextromethorphan Hydrobromide (10mg/5ml). This syrup is indicated for the symptomatic relief of upper respiratory tract conditions characterized by nasal congestion, allergic rhinitis, and cough. Phenylephrine acts as a selective alpha-1 adrenergic receptor agonist, providing effective nasal decongestion by vasoconstriction of the nasal mucosa. Chlorpheniramine Maleate is a first-generation antihistamine that alleviates allergic symptoms such as sneezing, runny nose, and itching by blocking H1 histamine receptors. Dextromethorphan Hydrobromide serves as a non-opioid antitussive agent, suppressing the cough reflex centrally without causing respiratory depression. Kuftive Syrup is suitable for adults and children above the recommended age, with dosing adjusted accordingly. It should be used cautiously in patients with hypertension, glaucoma, or thyroid disorders due to the sympathomimetic effects of phenylephrine. Common adverse reactions may include drowsiness, dizziness, dry mouth, and gastrointestinal disturbances. Contraindications include hypersensitivity to any component and concurrent use with monoamine oxidase inhibitors. Kuftive Syrup should be used under medical supervision, adhering to prescribed dosages to ensure safety and efficacy in managing cold and allergy-related symptoms.